中国医药导刊
中國醫藥導刊
중국의약도간
CHINESE JOURNAL OF MEDICAL GUIDE
2012年
12期
2112
,共1页
汤璐敏%陈素英%李祎群%李鹤%沈惠风
湯璐敏%陳素英%李祎群%李鶴%瀋惠風
탕로민%진소영%리의군%리학%침혜풍
尿路感染%清炎颗粒%临床疗效%安全性
尿路感染%清炎顆粒%臨床療效%安全性
뇨로감염%청염과립%림상료효%안전성
Urinary tract infection%Qingyan granula%Therapeutic effect%Security
目的:观察清炎颗粒治疗尿路感染的临床疗效及安全性研究.方法:将109例尿路感染患者随机分成2组,治疗组78例,予清炎颗粒;对照组31例,予环丙沙星胶囊.结果:治疗组总有效率为88.5%,治疗组与对照组总有效率无显著性差异(P>0.05),治疗前后肝肾功能无明显变化(P>0.05).结论:清炎颗粒治疗尿路感染疗效与环丙沙星相当,是有效的,安全的.
目的:觀察清炎顆粒治療尿路感染的臨床療效及安全性研究.方法:將109例尿路感染患者隨機分成2組,治療組78例,予清炎顆粒;對照組31例,予環丙沙星膠囊.結果:治療組總有效率為88.5%,治療組與對照組總有效率無顯著性差異(P>0.05),治療前後肝腎功能無明顯變化(P>0.05).結論:清炎顆粒治療尿路感染療效與環丙沙星相噹,是有效的,安全的.
목적:관찰청염과립치료뇨로감염적림상료효급안전성연구.방법:장109례뇨로감염환자수궤분성2조,치료조78례,여청염과립;대조조31례,여배병사성효낭.결과:치료조총유효솔위88.5%,치료조여대조조총유효솔무현저성차이(P>0.05),치료전후간신공능무명현변화(P>0.05).결론:청염과립치료뇨로감염료효여배병사성상당,시유효적,안전적.
Objective:To evaluate therapeutic effect and Security of Qingyan Granula.Methods:Total 109 patients were randomly divided into treatment group and control group.Qingyan granula was used in treatment group while ciprofloxacin capsule was used in control group. Results:(1)The total effective rate of treatment group was 88.5% The total effective rate of treatment group was no significant difference between that of control group (P>0.05).The liver, renal function had no significant change before and after treatment .Conclusion:The application of Qingyan granula in urinary tract infection is effective, safe.
